CNS

Digital

Everyday drug discovery: How tech expands the potential of c...

Discover how technology is making clinical trials more flexible and patient-friendly through tools like eCOA, eConsent, and wearables.

Patients

Real-world evidence in CNS research: Past, present, future

Large-scale, multi-country real-world evidence (RWE) studies—including in Central Nervous System (CNS) indications—have the potential to deliver critical new insights.

R&D

Shifting paradigms of clinical trial design accelerate CNS R...

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed.

News

NHSBSA releases latest Medicines Used in Mental Health data

Covering October to December 2022, the report recorded 21.7m antidepressant items prescribed.

Patients

It’s time to do better for patients with rare neurological d...

Global Gene’s Craig Martin introduces a new patient identification initiative that strives to improve diagnosis and access to clinical trials for all patients with rare CNS conditions.

Events